Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01372254 · ClinicalTrials.gov registry record · Phase 1
Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment
A Phase 1 study, sponsored by University of Maryland, College Park.
- Completed
- Registry status
- Phase 1
- Development phase
- 96
- Enrollment target
NCT01372254 is a Phase 1 study that has completed, run by University of Maryland, College Park. The registered enrollment target is 96 participants.
The verdict
NCT01372254, a Phase 1 study, has completed, sponsored by University of Maryland, College Park.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 96 participants
- Enrollment target
Study Summary
The objective of the proposed project is to develop a novel, behavioral approach to smoking cessation that can be integrated with residential drug use treatment for low income substance using smokers with elevated depressive symptoms. The approach utilizes behavioral activation strategies which have been shown to reduce smoking among community samples and which can be easily targeted for the particular needs of low income substance users.
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL Standard Treatment
- BEHAVIORAL BAD-AS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2011-12 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01372254
The ClinicalTrials.gov registry entry for NCT01372254 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, College Park, which has 46 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT01372254 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01372254 about?
NCT01372254 is a clinical study titled "Behavioral Intervention for Low Income Depressed Smokers in Drug Treatment". The objective of the proposed project is to develop a novel, behavioral approach to smoking cessation that can be integrated with residential drug use treatment for low income substance using smokers with elevated depressive symptoms. The approach utilizes behavioral activation strategies which have...
What is the current status of trial NCT01372254?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 96 participants. The study started on 2011-12. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01372254?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Standard Treatment (BEHAVIORAL), BAD-AS (BEHAVIORAL).
Who is sponsoring clinical trial NCT01372254?
This trial is sponsored by University of Maryland, College Park, which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.